Clinical Trial Update: A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing cabozantinib in Japanese patients with advanced hepatocellular carcinoma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Takeda | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-04-18